118 related articles for article (PubMed ID: 12901346)
1. Pathogenic markers in essential thrombocythemia.
Gale RE
Curr Hematol Rep; 2003 May; 2(3):242-7. PubMed ID: 12901346
[TBL] [Abstract][Full Text] [Related]
2. PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia.
Vannucchi AM; Grossi A; Pancrazzi A; Antonioli E; Guglielmelli P; Balestri F; Biscardi M; Bulgarelli S; Longo G; Graziano C; Gugliotta L; Bosi A
Br J Haematol; 2004 Oct; 127(2):214-9. PubMed ID: 15461629
[TBL] [Abstract][Full Text] [Related]
3. Detection of abnormalities of PRV-1, TPO, and c-MPL genes detected by fluorescence in situ hybridization in essential thrombocythemia.
Puigdecanet E; Espinet B; Villa O; Florensa L; Besses C; Serrano S; Solé F
Cancer Genet Cytogenet; 2006 May; 167(1):39-42. PubMed ID: 16682284
[TBL] [Abstract][Full Text] [Related]
4. Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines.
Dillon M; Minear J; Johnson J; Lannutti BJ
Leuk Res; 2008 May; 32(5):811-9. PubMed ID: 17980909
[TBL] [Abstract][Full Text] [Related]
5. Current evaluation of the clinical, diagnostic, and therapeutic usefulness of prv-1 and c-mpl markers in polycythemia vera and essential thrombocythemia.
Pahl HL
Clin Adv Hematol Oncol; 2004 Apr; 2(4):202, 204. PubMed ID: 16163180
[No Abstract] [Full Text] [Related]
6. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
7. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.
Johansson P; Ricksten A; Wasslavik C; Johansson B; Andréasson B
Haematologica; 2004 Oct; 89(10):1264-6. PubMed ID: 15477215
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
9. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC
Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591
[TBL] [Abstract][Full Text] [Related]
10. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin.
Liu E; Jelinek J; Pastore YD; Guan Y; Prchal JF; Prchal JT
Blood; 2003 Apr; 101(8):3294-301. PubMed ID: 12515724
[TBL] [Abstract][Full Text] [Related]
11. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytosis and thrombocythemia.
Schafer AI
Blood Rev; 2001 Dec; 15(4):159-66. PubMed ID: 11792116
[TBL] [Abstract][Full Text] [Related]
13. Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management.
Tefferi A; Murphy S
Blood Rev; 2001 Sep; 15(3):121-31. PubMed ID: 11735160
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia.
Teofili L; Martini M; Luongo M; Di Mario A; Leone G; De Stefano V; Larocca LM
J Clin Oncol; 2002 Oct; 20(20):4249-54. PubMed ID: 12377969
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders.
Kralovics R; Skoda RC
Blood Rev; 2005 Jan; 19(1):1-13. PubMed ID: 15572213
[TBL] [Abstract][Full Text] [Related]
16. Circulating thrombopoietin in clonal versus reactive thrombocytosis.
Karakuş S; Ozcebe OI; Haznedaroğlu IC; Göker H; Ozatli D; Koşar A; BüyükaşIk Y; Ertuğrul D; SayInalp N; KirazlI S; Dündar SV
Hematology; 2002 Feb; 7(1):9-12. PubMed ID: 12171772
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic control of PRV-1 expression on neutrophils.
Jelinek J; Li J; Mnjoyan Z; Issa JP; Prchal JT; Afshar-Kharghan V
Exp Hematol; 2007 Nov; 35(11):1677-83. PubMed ID: 17976520
[TBL] [Abstract][Full Text] [Related]
18. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
Florena AM; Tripodo C; Iannitto E; Porcasi R; Ingrao S; Franco V
Haematologica; 2004 Aug; 89(8):911-9. PubMed ID: 15339673
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
[TBL] [Abstract][Full Text] [Related]
20. PRV-1 mRNA expression discriminates two types of essential thrombocythemia.
Griesshammer M; Klippel S; Strunck E; Temerinac S; Mohr U; Heimpel H; Pahl HL
Ann Hematol; 2004 Jun; 83(6):364-70. PubMed ID: 15034760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]